Developmental Neurotoxivity of Industrial Chemicals
Lancet 368:2167-2178, Grandjean,P. &Landrigan,P.J., 2006
Cranial MR Findings in Chronic Toluene Abuse by Inhalation
AJNR 23:1173-1179,1072, Aydin, K.,et al, 2002
Toluene Abuse Causing Reduced MR Signal Intensity in the Brain
AJR 161:1259-1261, Caldemeyer,K.S.,et al, 1993
Delay in P300 Latency in Patients with Organic Solvent Exposure
Arch Neurol 49:315-320, Morrow,L.A.,et al, 1992
Acquired Pendular Nystagmus in Toluene Addiction
Neurol 41:282-285, Maas,E.F.,et al, 1991
White Matter Dementia in Chronic Toluene Abuse
Neurol 40:532-534, Filley,C.M.,et al, 1990
Toluene Abuse Causes Diffuse Central Nervous System White Matter Changes
Ann Neurol 23:611-614, Rosenberg,N.L.,et al, 1988
Neurologic Sequelae of Chronic Solvent Vapor Abuse
Neurol 36:698-702, Hormes,J.T.,et al, 1986
Multifocal Central Nervous System Damage Caused by Toluene Abuse
Neurol 33:1337-1340, Lazar,R.B.,et al, 1983
Abnormal Brainstem Auditory Evoked Potentials in Chronic Paint Sniffers
Ann Neurol 12:553-556, Metrick,S.A.,et al, 1982
Status Epilepticus Caused by Solvent Abuse
BMJ 283:1156, Allister,C.,et al, 1981
Hypokalemic Periodic Paralysis in Chronic Toluene Exposure
Arch Neurol 37:673, Bennett,R.H.,et al, 1980
Toluene Optic Neuropathy
Ann Neurol 4:390, Keane,J.R., 1978
Persistent Cerebellar Ataxia after Exposure to Toluene
Ann Neurol 2:440, Boor,J.W.,et al, 1977
Drug Abuse in Our Community
MCV Quart 6:130, Bright,G.M., 1970
Antibody-Mediated Encephalitis
NEJM 378:840-851, Dalmau, J.,et al, 2018
Glutamate Receptor D2 Serum Antibodies in Pediatric Opsoclonus Myoclonus Ataxia Syndrome
Neurol 91:e714-e723, Berridge, G.,et al, 2018
Autoimmune Encephalitides: A Broadening Field of Treatable Conditions
Neurologist 22:1-13, Kalman, B., 2017
Encephalitis and AMPA Receptor Antibodies
Neurol 84:2403-2412, Hoftberger, R.,et al, 2015
Clinical Spectrum of Encephalitis Associated with Antibodies Againts the a-Amino-3-Hydroxy-5-Methyl-4-Isoxazoleproprionic Acid Receptor
JAMA Neurol 72:1163-1169, Joubert, B.,et al, 2015
Recognizing Autoimmune-Mediated Encephalitis in the Differential Diagnosis of Limbic Disorders
AJNR 36:2196-2205, da Rocha, A.J.,et al, 2015
Encephalitis and antibodies to synaptic and neuronal cell surface proteins
Neurol 77:179-189, Lancaster, E.,et al, 2011
The Expanding Clinical Profile of Anti-AMPA Receptor Encephalitis
Neurol 74:857-859, Graus,F.,et al, 2010
Reversible Paraneoplpastic Limbic Encephalitis Associated with Antibodies to the AMPA Receptor
Neurol 74:265-267, Bataller,L.,et al, 2010
Diagnostic Value of N-methyl-D-aspartate Receptor Antibodies in Women with New-Onset Epilepsy
Arch Neurol 66:458-464, Niehusmann,P.,et al, 2009
Paraneoplastic Syndromes Affecting Brain and Cranial Nerves
UpToDate May 2009, Dalmau,J. &Rosenfeld,M., 2009
Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008
Anti-NMDA Receptor Encephalitis in Japan: Long-Term Outcome Without Tumor Removal
Neurol 70:504-511,500, Iizuka,T.,et al, 2008
Paraneoplastic Anti-N-methyl-D-aspartate Receptor Encephalitis Associated With Ovarian Teratoma
Ann Neurol 61:25-36,3, Dalmau,J.,et al, 2007
Methyl Bromide Intoxication Causes Reversible Symmetric Branstem and Cerebellar MRI Lesions
Neurol 64:1279-1281, Geyer,H.L.,et al, 2005
Occupational Exposure to Methyl Isobutyl Ketone Causes Lasting Impairment in Working Memory
Neurol 54:1853-1855, Grober,E.&Schaumburg,H.H., 2000
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
NEJM 330:613-622, Lipton,S.A.&Rosenberg,P.A., 1994
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
NEJM 330:585-591, Bensimon,G.,et al, 1994
Migraine-Related Stroke in Childhood
Lancet 337:825-826, , 1991
N-Methyl-D-Aspartate Antagonists in the Treatment of Parkinson's Disease
Arch Neurol 48:977-981, Greenamyre,J.T.&O'Brien,C.F., 1991
The Bioloigcal Basis for the Treatment of Acute Stroke
Neurol 41:1867-1873, Scheinberg,P., 1991
Abnormalities of Striatal Projection Neurons and n-Methyl-d-Aspartate Receptors in Presymptomatic Huntington's Disease
NEJM 322:1293-1298, Albin,R.L.,et al, 1990
Anatomy, Physiology, and Pathology of Epilepsy
lancet 336:231-232, Meldrum,B.S., 1990
Levodopa Methyl Ester Treatment of Parkinson's Disease
Neurol 37:1242-1245, Juncos,J.L.,et al, 1987
Classification of Parkinsonism
in Handbook of Parkinson's Disease, Marcel Dekker, Inc, New York, Ch 3, p 61., Koller,W.C., 1987
Methyl Bromide Poisoning Seen Initially as Psychosis
Arch Neurol 38:529-530, Zatuchni,J.,et al, 1981
Randomized Comparisons Of Radiotherapy & Nitrosoureas For The Treatment Of Malignant Glioma After Surgery
NEJM 303:1323-1329, Walker,M.D.,et al, 1980
Exacerbation of Parkinsonism by Methyldopa
JAMA 244:2727-2728, Rosenblum,A.M.&Montgomery,E.B., 1980
Methyl Bromide Intoxication:Neurologic Features, Including Simulation of Reye Syndrome
Neurol 27:959, Shield,L.K.,et al, 1977
Dementia Induced by Methyldopa with Haloperidol
NEJM 295:1222, Thorton,W.E., 1976
Adjuvant Nitrosourea Therapy for Glioblastoma
Arch Neurol 33:745, Brisman,R.,et al, 1976
Neuropathy & Methyl N-Butyl Ketone
NEJM Letter:290 1263; 1974., , 1974
Modern Treatment of Parkinson's Disease
Excerpta Medica, 2:1972 Sept., , 1972
Methyldopahydrazine as an Adjunct to L-Dopa Therapy in Parkinsonism
Neurol 22:384, Chase,T.,et al, 1972